Nanotech Capital Raises in the U.S. – January 16th-31st, 2025
Some interesting transactions closed in the Nanotech sector over the past two weeks. If you would like more information on these deals or would like to discuss the capital raising market for your company, please contact me.
Merger/Acquisition and Corporate
-
- Matrix F.T., a developer of IP-backed three-dimensional nanofiber scaffolds designed to help clients in the production of cultivated meat, was acquired by Nexture Bio.
- Molecular Assemblies, a developer of enzymatic deoxyribonucleic acid synthesis technology designed to power next-generation deoxyribonucleic acid-based products, was acquired by Maravai LifeSciences.
Later Stage VC
-
- EVOQ Nano, a developer of an antimicrobial technology designed to create precise novel product outcomes for numerous applications and for multiple drug administration pathways, raised $18 million in venture funding from Tony Robbins.
- GreenMark Biomedical, an operator of a minimally invasive healthcare platform intended to deliver health-based benefits through biobased targeting technologies, raised $500,000 in venture funding in the form of SAFE notes.
- ONIT Sciences, an operator of an agriculture technology company focused on increasing plant and human health through organic natural input technologies, raised $20,000 in venture funding.
Angel, Seed, and Grant
-
- TMTP Labs, an operator of a research and development center intended for nanotechnology, raised $50,000 in angel funding.
- NovoLINC, a developer of advanced thermal interface materials intended to enhance heat management in high-performance applications, raised $2.00 million through a combination in Seed-1 and Seed-2 funding in a deal led by M Ventures.
#castleplacement #capitalraising #privateequity #venturecapital #investment #nanotech
Jesus Tueme
Managing Director
Finance and banking executive with a global perspective, broad professional practice and extensive network in Latin America. 22 years at BBVA, BNPP and Credit Agricole. Successful deal-making track record with multinationals, major Latin American issuers and government agencies. Extensive experience in restructuring/special situations, initial public offerings, corporate strategy, evaluating alliances, mergers and acquisitions, corporate governance, risk management, customer centric and digital strategies, and financial analytics. BS in Economics from Mexico Monterrey Institute of Technology. MBA from the University of California Los Angeles in 1987. Graduated from Harvard Business School General Management Program. Further academic work on Risk Management at Stanford University and as a research and finance scholar at the Monterrey Institute of Technology.
- Email: jtueme@castleplacement.com
- (C) (646) 479-7616
 Jesus TuemeManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: jtueme@castleplacement.com
(C) (646) 479-7616
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement™ does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
